Expression of subcutaneous adipose tissue phosphoenolpyruvate carboxykinase correlates with body mass index in nondiabetic women

Metabolism: Clinical and Experimental

Volumn 57, Issue 3, 2008, Pages 367-372

  Chang, Tien Jyun ^a   Lee, Wei Jei ^b   Chang, Hui Min ^a   Lee, Kuan Ching ^a   Chuang, Lee Ming ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MIDDLE AGED; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 38749131286     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.10.012     Document Type: Article

References (35)

1. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F.J., and Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280 (2001) E827-E847
2. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2002) 697-738
3. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 18 Suppl 2 (2002) S5-S9
4. Dresner A., Laurent D., Marcucci M., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103 (1999) 253-259
5. Griffin M.E., Marcucci M.J., Cline G.W., et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
6. Vaughan M.J. The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem 237 (1962) 3354-3358
7. Zimmermann R., Strauss J.G., Haemmerle G., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306 (2004) 1383-1386
8. Ballard F.J., Hanson R.W., and Leveille G.A. Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J Biol Chem 242 (1967) 2746-2750
9. Reshef L., Olswang Y., Cassuto H., et al. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem 278 (2003) 30413-30416
10. Botion L.M., Kettelhut I.C., and Migliorini R.H. Increased adipose tissue glyceroneogenesis in rats adapted to a high protein, carbohydrate-free diet. Horm Metab Res 27 (1995) 310-313
11. Reshef L., Hanson R.W., and Ballard F.J. A possible physiological role for glyceroneogenesis in rat adipose tissue. J Biol Chem 245 (1970) 5979-5984
12. Olswang Y., Cohen H., Papo O., et al. A mutation in the peroxisome proliferator-activated receptor γ-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci U S A 99 (2002) 625-630
13. Franckhauser S., Munoz S., Pujol A., et al. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 51 (2002) 624-630
14. Hanson R.W., and Reshef L. Regulation of phosphoenolpyruvate carboxykinase(GTP) gene expression. Annu Rev Biochem 66 (1997) 581-611
15. Forest C., Franckhauser S., Glorian M., Antras-Ferry J., Robin D., and Robin P. Regulation of gene transcription by fatty acids, fibrates and prostaglandins: the phosphoenolpyruvate carboxykinase gene as a model. Prostaglandins Leukot Essent Fatty Acids 57 (1997) 47-56
16. Beale E.G., Hammer R.E., Antoine B., and Forest C. Dysregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 15 (2004) 129-135
17. Tordjman J., Chauvet G., Quette J., Beale E.G., Forest C., and Antoine B. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 278 (2003) 18785-18790
18. Glorian M., Duplus E., Beale E.G., Scott D.K., Granner D.K., and Forest C. A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Biochimie 83 (2001) 933-943
19. Bogacka I., Xie H., Bray G.A., and Smith S.R. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 27 (2004) 1660-1667
20. Duplus E., Benelli C., Reis A.F., Fouque F., Velho G., and Forest C. Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie 85 (2003) 1257-1264
21. Hani E.H., Zouali H., Philippi A., et al. Indication for genetic linkage of the phosphoenolpyruvate carboxykinase (PCK1) gene region on chromosome 20q to non-insulin-dependent diabetes mellitus. Diabetes Metab 22 (1996) 451-454
22. Zouali H., Hani E.H., Philippi A., et al. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 6 (1997) 1401-1408
23. Klupa T., Malecki M.T., Pezzolesi M., et al. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes 49 (2000) 2212-2216
24. Modan M., Halkin H., Almog S., et al. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 75 (1985) 809-817
25. Corella D., and Ordovas J.M. The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis. Curr Atheroscler Rep 6 (2004) 186-196
26. Drenick E.J. Definition and health consequences of morbid obesity. Surg Clin North Am 59 (1979) 963-976
27. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
28. Yang W.S., Chen M.H., Lee W.J., et al. Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. Int J Obes Relat Metab Disord 27 (2003) 896-900
29. Yang W.S., Lee W.J., Huang K.C., et al. mRNA levels of the insulin-signaling molecule SORBS1 in the adipose depots of nondiabetic women. Obes Res 11 (2003) 586-590
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
31. Deurenberg P., Weststrate J.A., and Seidell J.C. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 65 (1991) 105-114
32. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258 (1992) 766-770
33. Franckhauser S., Munoz S., Elias I., Ferre T., and Bosch F. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity. Diabetes 55 (2006) 273-280
34. Mori Y., Murakawa Y., Okada K., et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22 (1999) 908-912
35. Lee J.H., Reed D.R., Li W.D., et al. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 64 (1999) 196-209